Holocene Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $530M | Buy |
679,699
+138,107
| +26% | +$108M | 1.29% | 8 |
|
|
2025
Q1 | $447M | Buy |
541,592
+115,278
| +27% | +$95.2M | 1.3% | 8 |
|
|
2024
Q4 | $329M | Sell |
426,314
-11,289
| -3% | -$8.72M | 1.05% | 13 |
|
|
2024
Q3 | $388M | Buy |
437,603
+315,065
| +257% | +$279M | 1.57% | 5 |
|
|
2024
Q2 | $111M | Buy |
122,538
+48,235
| +65% | +$43.7M | 0.46% | 71 |
|
|
2024
Q1 | $57.8M | Sell |
74,303
-32,778
| -31% | -$25.5M | 0.21% | 139 |
|
|
2023
Q4 | $62.4M | Buy |
107,081
+15,275
| +17% | +$8.9M | 0.24% | 127 |
|
|
2023
Q3 | $49.3M | Buy |
+91,806
| New | +$49.3M | 0.22% | 136 |
|
|
2021
Q4 | – | Sell |
-183,112
| Closed | -$42.3M | – | 921 |
|
|
2021
Q3 | $42.3M | Buy |
+183,112
| New | +$42.3M | 0.23% | 123 |
|
|
2021
Q2 | – | Sell |
-103,209
| Closed | -$19.3M | – | 874 |
|
|
2021
Q1 | $19.3M | Buy |
+103,209
| New | +$19.3M | 0.12% | 171 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 780 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 712 |
|
|
2018
Q2 | – | Sell |
-3,282
| Closed | -$254K | – | 641 |
|
|
2018
Q1 | $254K | Sell |
3,282
-5,284
| -62% | -$409K | 0.01% | 430 |
|
|
2017
Q4 | $723K | Buy |
+8,566
| New | +$723K | 0.02% | 292 |
|